South Korean regulator the Ministry of Food and Drug Safety (MFDS) is removing spirulina’s skin health functional claim and has also changed the requirements of eight other raw materials.
A new start-up from China, Ortu, has released a clean label skin health supplement on Tmall said to cater to all genders, ages and skin colours, and eschewing the traditional lightening claims.
Probiotics have boomed in China in recent years, accounting for almost half of Asia’s sales, but the nation’s infant nutrition market has begun slow, leading experts to call for more innovation and products with added functionality.
From multivitamin supplementation and COVID-19 severity, to Nestle Japan's new launch, and Bayer's e-commerce sales growth, here is a round-up of the most-read stories in December.
Novel formats and high profit margins are some of the key areas that Wellnex Life will focus on as it expands the presence of its nutrition and supplement products across major retailers in Australia.
From manuka honey to peanut butter and fermented kelp drinks, New Zealand has announced new investment projects related to the research or creation of new functional food products.
Australia start-up Funday Natural Sweets is on a mission to increase its presence from 1,000 outlets to 3,000 next year, in addition to unveiling plans to expand internationally.
Uttar Pradesh-based Zeon Lifesciences is ramping up its offerings in the botanicals, phyto-pharmaceuticals, and medical nutrition space via research and commercialisation partnerships with several local institutes.
We spoke with industry experts from Nestle, Morinaga, Max Biocare and Shiseido to find out their 2022 predictions for health and nutrition trends, spanning insights across healthy ageing, infant nutrition, kids’, women’s, and men’s health.
ASX-listed Fiji Kava says it is anticipating strong demand for its kava drinking powder following a lift on the import ban into country, first imposed in 2007.
Astaxanthin combined with celecoxib, a drug used to treat pain and inflammation, can lower uric acid levels in people with gouty arthritis, more significantly than celecoxib alone.